ResMed Inc. (RMD): A Bull Case Theory
We came across a bullish thesis on ResMed Inc. (RMD) on Substack by LongTermValue Research. In this article, we will summarize the bulls’ thesis on RMD. ResMed Inc.
Resmed Inc (RMD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | AQR Capital Management Cliff Asness | 625,054 | $142,943,590 | +134% | 0.18% |
| 2. | 481,700 | $110,159,973 | -55% | 0.43% | |
| 3. | Renaissance Technologies Jim Simons | 247,700 | $56,646,513 | +195% | 0.08% |
| 4. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 216,127 | $49,426,084 | +10% | 0.03% |
| 5. | 137,600 | $31,467,744 | +35% | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $69.13 | 2,487 | Director | 19,216 | 2016-08-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $222.86 | 64 | Officer | 8,846 | 2025-04-01 | Filing | |
| $230.36 | 1,000 | Officer | 90,864 | 2025-03-10 | Filing | |
| $239.31 | 9,745 | Officer | 9,725 | 2025-03-10 | Filing | |
| $229.20 | 8,009 | Officer | 455,472 | 2025-03-07 | Filing | |
| $227.71 | 2,000 | Director | 75,218 | 2025-03-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 118,595 | $26,547,560 | 0.38% | |
| 2. | 68,739 | $15,387,225 | 0.45% |
News See All
Jim Cramer is Discussing These 10 Stocks Ahead of Q1 Earnings Season
Jim Cramer in a latest program on CNBC talked about the winning sectors so far this year and said the trends show a "strange" pattern.
Jim Cramer Recently Talked About These 12 Companies
Jim Cramer, host of Mad Money, warned investors on Friday that until there is more clarity regarding the tariff situation, they should brace for continued volatility.
ResMed Inc. (NYSE:RMD) Q2 2025 Earnings Call Transcript
Operator: Welcome to the Q2 Fiscal Year 2025 ResMed Earnings Conference Call. My name is Matt, and I'll be your operator for today's call. At this time, all participants are in a listen-only mode.
ResMed (RMD) Rose 15% in Q3
Fidelity Investments, an investment management company, recently released its “Fidelity Growth Strategies Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
ResMed Inc. (NYSE:RMD) Q1 2025 Earnings Call Transcript
Operator: Hello, and welcome to the Q1 Fiscal Year 2025 ResMed Earnings Conference Call. My name is Kevin, and I'll be your operator for today's call.
ResMed Inc. (NYSE:RMD) Q4 2024 Earnings Call Transcript
Operator: Hello, and welcome to the Q4 Fiscal Year 2024 ResMed Earnings Conference Call. My name is Kevin, and I'll be your operator for today's call.
ResMed Inc. (NYSE:RMD) Q3 2024 Earnings Call Transcript
ResMed Inc. beats earnings expectations. Reported EPS is $2.13, expectations were $1.91. ResMed Inc.
20 Fastest Growing Health Tech Companies in the World
In this article, we will be taking a look at the 20 fastest growing health tech companies in the world.
25 Most Valuable Medical Device Companies in the US
In this article, we will be taking a look at the 25 most valuable medical device companies in the US.
Billionaire Hedge Funds
